Isoprenoids influence expression of Ras and Ras-related proteins

Sarah A Holstein, Christine L. Wohlford-Lenane, Raymond J. Hohl

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

Mevalonate depletion by inhibition of hydroxymethylglutaryl coenzyme A reductase impairs post-translational processing of Ras and Ras-related proteins. We have previously shown that this mevalonate depletion also leads to the upregulation of Ras, Rap1a, RhoA, and RhoB. This upregulation may result from global inhibition of isoprenylation or depletion of key regulatory isoprenoid species. Studies utilizing specific isoprenoid pyrophosphates in mevalonate-depleted cells reveal that farnesyl pyrophosphate (FPP) restores Ras processing and prevents RhoB upregulation while geranylgeranyl pyrophosphate (GGPP) restores Rap1a processing and prevents RhoA and RhoB upregulation. Either FPP or GGPP completely prevents lovastatin-induced upregulation of RhoB mRNA. Inhibition of FPP or squalene synthase allowed for the further identification of the putative regulatory species. Studies involving the specific isoprenyl transferase inhibitors FTI-277 and GGTI-286 demonstrate that selective inhibition of protein isoprenylation does not mimic lovastatin's ability to increase Ras and RhoA synthesis, decrease Ras and RhoA degradation, increase RhoB mRNA, or increase total levels of Ras, Rap1a, RhoA, and RhoB. In aggregate, these findings reveal a novel role and mechanism for isoprenoids to influence levels of Ras and Ras-related proteins.

Original languageEnglish (US)
Pages (from-to)13698-13704
Number of pages7
JournalBiochemistry
Volume41
Issue number46
DOIs
StatePublished - Nov 19 2002

Fingerprint

ras Proteins
Mevalonic Acid
Terpenes
Lovastatin
Up-Regulation
Farnesyl-Diphosphate Farnesyltransferase
Processing
Messenger RNA
Proteins
Diphosphates
Coenzyme A
Transferases
Protein Prenylation
Oxidoreductases
Prenylation
Degradation
farnesyl pyrophosphate
geranylgeranyl pyrophosphate

ASJC Scopus subject areas

  • Biochemistry

Cite this

Isoprenoids influence expression of Ras and Ras-related proteins. / Holstein, Sarah A; Wohlford-Lenane, Christine L.; Hohl, Raymond J.

In: Biochemistry, Vol. 41, No. 46, 19.11.2002, p. 13698-13704.

Research output: Contribution to journalArticle

Holstein, Sarah A ; Wohlford-Lenane, Christine L. ; Hohl, Raymond J. / Isoprenoids influence expression of Ras and Ras-related proteins. In: Biochemistry. 2002 ; Vol. 41, No. 46. pp. 13698-13704.
@article{ad6006d740454922989fecaa49e3e86c,
title = "Isoprenoids influence expression of Ras and Ras-related proteins",
abstract = "Mevalonate depletion by inhibition of hydroxymethylglutaryl coenzyme A reductase impairs post-translational processing of Ras and Ras-related proteins. We have previously shown that this mevalonate depletion also leads to the upregulation of Ras, Rap1a, RhoA, and RhoB. This upregulation may result from global inhibition of isoprenylation or depletion of key regulatory isoprenoid species. Studies utilizing specific isoprenoid pyrophosphates in mevalonate-depleted cells reveal that farnesyl pyrophosphate (FPP) restores Ras processing and prevents RhoB upregulation while geranylgeranyl pyrophosphate (GGPP) restores Rap1a processing and prevents RhoA and RhoB upregulation. Either FPP or GGPP completely prevents lovastatin-induced upregulation of RhoB mRNA. Inhibition of FPP or squalene synthase allowed for the further identification of the putative regulatory species. Studies involving the specific isoprenyl transferase inhibitors FTI-277 and GGTI-286 demonstrate that selective inhibition of protein isoprenylation does not mimic lovastatin's ability to increase Ras and RhoA synthesis, decrease Ras and RhoA degradation, increase RhoB mRNA, or increase total levels of Ras, Rap1a, RhoA, and RhoB. In aggregate, these findings reveal a novel role and mechanism for isoprenoids to influence levels of Ras and Ras-related proteins.",
author = "Holstein, {Sarah A} and Wohlford-Lenane, {Christine L.} and Hohl, {Raymond J.}",
year = "2002",
month = "11",
day = "19",
doi = "10.1021/bi026251x",
language = "English (US)",
volume = "41",
pages = "13698--13704",
journal = "Biochemistry",
issn = "0006-2960",
publisher = "American Chemical Society",
number = "46",

}

TY - JOUR

T1 - Isoprenoids influence expression of Ras and Ras-related proteins

AU - Holstein, Sarah A

AU - Wohlford-Lenane, Christine L.

AU - Hohl, Raymond J.

PY - 2002/11/19

Y1 - 2002/11/19

N2 - Mevalonate depletion by inhibition of hydroxymethylglutaryl coenzyme A reductase impairs post-translational processing of Ras and Ras-related proteins. We have previously shown that this mevalonate depletion also leads to the upregulation of Ras, Rap1a, RhoA, and RhoB. This upregulation may result from global inhibition of isoprenylation or depletion of key regulatory isoprenoid species. Studies utilizing specific isoprenoid pyrophosphates in mevalonate-depleted cells reveal that farnesyl pyrophosphate (FPP) restores Ras processing and prevents RhoB upregulation while geranylgeranyl pyrophosphate (GGPP) restores Rap1a processing and prevents RhoA and RhoB upregulation. Either FPP or GGPP completely prevents lovastatin-induced upregulation of RhoB mRNA. Inhibition of FPP or squalene synthase allowed for the further identification of the putative regulatory species. Studies involving the specific isoprenyl transferase inhibitors FTI-277 and GGTI-286 demonstrate that selective inhibition of protein isoprenylation does not mimic lovastatin's ability to increase Ras and RhoA synthesis, decrease Ras and RhoA degradation, increase RhoB mRNA, or increase total levels of Ras, Rap1a, RhoA, and RhoB. In aggregate, these findings reveal a novel role and mechanism for isoprenoids to influence levels of Ras and Ras-related proteins.

AB - Mevalonate depletion by inhibition of hydroxymethylglutaryl coenzyme A reductase impairs post-translational processing of Ras and Ras-related proteins. We have previously shown that this mevalonate depletion also leads to the upregulation of Ras, Rap1a, RhoA, and RhoB. This upregulation may result from global inhibition of isoprenylation or depletion of key regulatory isoprenoid species. Studies utilizing specific isoprenoid pyrophosphates in mevalonate-depleted cells reveal that farnesyl pyrophosphate (FPP) restores Ras processing and prevents RhoB upregulation while geranylgeranyl pyrophosphate (GGPP) restores Rap1a processing and prevents RhoA and RhoB upregulation. Either FPP or GGPP completely prevents lovastatin-induced upregulation of RhoB mRNA. Inhibition of FPP or squalene synthase allowed for the further identification of the putative regulatory species. Studies involving the specific isoprenyl transferase inhibitors FTI-277 and GGTI-286 demonstrate that selective inhibition of protein isoprenylation does not mimic lovastatin's ability to increase Ras and RhoA synthesis, decrease Ras and RhoA degradation, increase RhoB mRNA, or increase total levels of Ras, Rap1a, RhoA, and RhoB. In aggregate, these findings reveal a novel role and mechanism for isoprenoids to influence levels of Ras and Ras-related proteins.

UR - http://www.scopus.com/inward/record.url?scp=0037137175&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037137175&partnerID=8YFLogxK

U2 - 10.1021/bi026251x

DO - 10.1021/bi026251x

M3 - Article

VL - 41

SP - 13698

EP - 13704

JO - Biochemistry

JF - Biochemistry

SN - 0006-2960

IS - 46

ER -